0001213900-23-081857.txt : 20231031
0001213900-23-081857.hdr.sgml : 20231031
20231031170829
ACCESSION NUMBER: 0001213900-23-081857
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231029
FILED AS OF DATE: 20231031
DATE AS OF CHANGE: 20231031
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Oron Assaf
CENTRAL INDEX KEY: 0001792310
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38762
FILM NUMBER: 231365590
MAIL ADDRESS:
STREET 1: C/O BIOMX LTD.
STREET 2: 7 PINHAS SAPIR ST., FLOOR 2
CITY: NESS ZIONA
STATE: L3
ZIP: 7414002
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BiomX Inc.
CENTRAL INDEX KEY: 0001739174
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 22 EINSTEIN ST., 4TH FLOOR
CITY: NESS ZIONA
STATE: L3
ZIP: 7414003
BUSINESS PHONE: (972) 72 394 2377
MAIL ADDRESS:
STREET 1: 22 EINSTEIN ST., 4TH FLOOR
CITY: NESS ZIONA
STATE: L3
ZIP: 7414003
FORMER COMPANY:
FORMER CONFORMED NAME: Chardan Healthcare Acquisition Corp.
DATE OF NAME CHANGE: 20180430
4
1
ownership.xml
X0508
4
2023-10-29
0
0001739174
BiomX Inc.
PHGE
0001792310
Oron Assaf
C/O BIOMX INC., 22 EINSTEIN ST., FLOOR 4
NESS ZIONA,
L3
7414003
ISRAEL
0
1
0
0
Chief Business Officer
0
Common Stock Options - Right to Buy
1.691
2023-10-29
4
D
0
155363
0
D
2027-03-26
Common Stock
0
0
D
Common Stock Options - Right to Buy
0.275
2023-10-29
4
A
0
155363
0
A
2027-03-26
Common Stock
0
0
D
Common Stock Options - Right to Buy
1.973
2023-10-29
4
D
0
82667
0
D
2028-05-22
Common Stock
0
0
D
Common Stock Options - Right to Buy
0.275
2023-10-29
4
A
0
82667
0
A
2028-05-22
Common Stock
0
0
D
Common Stock Options - Right to Buy
2.031
2023-10-29
4
D
0
46966
0
D
2029-03-29
Common Stock
0
0
D
Common Stock Options - Right to Buy
0.275
2023-10-29
4
A
0
46966
0
A
2029-03-29
Common Stock
0
0
D
The reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on 03/26/2017 and provides for vesting over four years, with 25% of the shares subject to the option vested on 03/26/2018, and the remainder vested in 12 equal quarterly installments over three years; provided, however, none of the "new" options may be exercised prior to October 29, 2024.
The reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on 05/22/2018 and provides for vesting over four years, with 25% of the shares subject to the option vested on 05/22/2019, and the remainder vested in 12 equal quarterly installments over three years; provided, however, none of the "new" options may be exercised prior to October 29, 2024.
The reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on 03/29/2019 and provides for vesting over four years, with 25% of the shares subject to the option vested on 03/29/2020, and the remainder vested in 12 equal quarterly installments over three years; provided, however, none of the "new" options may be exercised prior to October 29, 2024.
/s/ Assaf Oron
2023-10-31